You are here: Home / Archives for Information

40 Billion Dollars Available for Mesothelioma Patients

October 30, 2009 By Leave a Comment

A mesothelioma diagnoses is devastating news for families who hear the news. Fortunately treatment options are progressing and more hospitals are skilled in addressing mesothelioma. In addition to the ability to file a lawsuit there is currently more than 40 billion dollars in bankruptcy trusts available for families dealing endothelium to help them pay bills and compensate them for their losses.

To find out if you qualify, fill out this Free Evaluation Form, or give us a call at 1-888-375-7600.

Filed Under: Asbestos Litigation, Mesothelioma Diagnosis, Mesothelioma Featured News, Mesothelioma Litigation

New Jersey & Pennsylvania Mesothelioma Cases Still on the Rise

October 30, 2009 By Leave a Comment

The number of people dying from the asbestos-related disease mesothelioma has hit record levels and is not expected to peak until 2016, according to research from the Health and Safety Executive. Unfortunately New Jersey and Pennsylvania Residents will bear a disproportionate burden of the rise in mesothelioma as there were more asbestos factories in New Jersey and Pennsylvania combined than anywhere else in the country. As a result the mesothleioma rates in Pennsylvania and New Jersey are higher than most other places in the United States.

The good news is that the treatment options are improving and people are living longer. New options bring new hope for mesothelioma patients and their families.

Mesothelioma is a virulent form of cancer that is almost always caused by exposure to asbestos. The disease is usually fatal.

In 2007, the most recent year for which data is available, 2,156 death certificates cited mesothelioma as cause of death. This was up from 2,058 in 2006 and 2,046 the year before that.

HSE researchers have forecast an increase in the number of men suffering from mesothelioma year-on-year until 2016. The figures project a rise from 1,812 cases of mesothelioma among males this year to 2,016.

Projections are exclusively for mesothelioma cases among men because a decision was taken to divide the research project in two by sex. Estimates for female deaths will be published in due course. The ratio of male to female deaths in 2007 was around five-to-one.

A spokesperson for the HSE insisted that asbestos was not just a legacy problem. “Asbestos exposure is very much a present danger. A complete ban on asbestos was not introduced until 2000 and there are still 500,000 non-domestic premises in the country with asbestos. It is Britain’s biggest industrial killer.”

He added that asbestos awareness was a crucial issue not just for tradesmen, but for facilities managers too. “As well as education tradesmen who might be exposed to asbestos we need to educate the dutyholders who are responsible.”

Filed Under: Mesothelioma Treatment Options

A Tribute to Mesothelioma Hero Vincent Cudiner

October 17, 2009 By Leave a Comment
When I first started representing people injured from exposure to asbestos, I was blessed to meet Vincent (Vinny) Cudiner. Vinny was a Local 12 insulator out of New York City who lived in New Jersey with his family. When I first met Vinny , he had been diagnosed with mesothelioma , a form of cancer only caused by exposure to asbestos. In those days, the treatment options were very limited and Vinny was acutely aware that the candle on his life was rapidly burning down.
Vincent ,even after diagnosis ,was an extremely handsome and charismatic man.
While Vinny had a limited education, he may very well have been a genius and was one of the kindest and most compassionate men I would ever meet. Vinny was truly a Renaissance man in every sense of the word with a character that even had the power over death for a while. The diagnosis of mesothelioma was a window through which I could see the strength and wisdom of this extraordinary person.
Even before being diagnosed with mesothelioma, Vinny made it part of his life mission to insure that others would not have to work with asbestos. After learning from Dr Irving Selikoff about the dangers of the products that he unwittingly worked with all of his life, Vinny took off from work and spent months in the US Patent office researching the ingredients in insulation materials. After extensive research, Vinny eventually developed an asbestos substitute which was patented.
After Vinny was diagnosed with mesothelioma, he was determined that others in his trade should not meet the same circumstances. Instead of sitting home, Vinny toured the country with Dr. Selikoff to speak with workers about the need to protect themselves from the asbestos already in place.
Vinny was a man who could see things in people and even nature that other men did not see. I can recall walking with Vinny along the shore of the Hudson River one day not too far from his home. While we were walking, he bent over and picked up a piece of wood that washed onto the shore and carried it home. When I asked Vinny why he chose that piece of wood, he responded that he could see something inside that he wanted to explore . The next time I came to visit , Vinny proudly pointed to a beautiful carving of a sailboat which he had created out of that very piece of wood.
Some months later when Vinny’s disease had progressed, he called me and asked me to visit him at his home. At that point my family was going through a very difficult time. My wife was lying in a hospital bed with an affliction that threatened to take her eyesight. When I arrived at the house, Vinny indicated that he had heard about my wife and was going to will his eyes to her when he passed on. I was speechless and to this day I get tears in my eyes every time I think of that moment.
A few weeks later I received a telephone call from Vinny asking me if I would come visit him. At this point Vinny was very sick and very frail. It was his 65th birthday. When I met with Vinny he told me that he knew he did not have long to live and wanted to thank me for all I had done. He also asked for my assurance that we would continue seek justice for his family after he was gone. The remainder of the story as a I recall it still weakens me in the knees. Vinny called each of his children into the room where he was lying one by one and spoke with them about what he expected from them and how he loved them. Lastly, he met alone with his beautiful wife Kari. During those final moments Vinny expressed his eternal love and devotion to Kari, kissed her goodbye and closed his eyes for the final time.
I later learned that Vinnys inner strength was for a time stronger than the forces that eventually took him. As the legend goes, so long as Vinny could live to 65 his family would have better benefits when he eventually passed. While Vinny had for a time power over death he certainly knew how to live life.
The Lawsuit
We filed a lawsuit on behalf on Vincent and his wife Kari in the New Jersey Superior Court. While he was alive, Vinny appeared for his deposition to answer questions about his asbestos exposure and his losses. The defense attorneys could not help but like him. The deposition turned into a course on asbestos products that no attorney in the room expected. Vinny would not only tell the attorneys what the product was used for, he would tell them the chemical composition, where it was made and even a little about the executives at the company. By the second day of his deposition, Vinny knew most of the lawyers by name and would often be found joking with them during breaks.
After Vinny, passed away the case was resolved very favorably. I felt like I kept my promise.
Many years later I often think of my friend and hero Vinny Cudiner and what he taught me about life, love and compassion. I Only wish that Vinny would have had available to him the treatment options and the hope that others diagnosed with mesothelioma now have.
Filed Under: Heroes, Information

Combination Therapy May Be Effective for Treatment of Mesothelioma

October 11, 2009 By Leave a Comment

An aggressive treatment strategy that begins with chemotherapy, followed by surgery, and then radiation is a safe and effective option for many mesothelioma patients, according to a recent study in The Annals of Thoracic Surgery.

Mesothelioma traditionally hasn’t responded well to just one treatment (surgery, chemotherapy, or radiation). In the early 1990s, Dr. David Sugarbaker of the Brigham and Women’s Hospital in Boston reported on the use of combining therapies. When he treated mesothelioma patients with extrapleural pneumonectomy (EPP—surgery to remove the diseased lung, as well as the diaphragm and the membrane covering the heart and lung), followed by chemotherapy and radiation, the results were promising.

Researchers at the Swedish Cancer Institute in Seattle, Washington, tried to replicate this triple-treatment approach, but they found it difficult to deliver chemotherapy after EPP. “Historically when giving chemotherapy after cancer surgery, we like to start doing it within 60 days, at the latest, of the surgery date,” explains Eric Vallières, MD, FRCSC, Surgical Director of the Swedish Cancer Institute’s Lung Cancer Program. “The problem with starting chemotherapy too ‘early,’ i.e., before full patient recovery, is that the chemo is too hard on them and they just quit.”

Instead of delivering chemotherapy after mesothelioma surgery, Dr. Vallières and his team decided to study the effectiveness and safety of beginning the treatment with chemotherapy, followed by surgery and then radiation. The reported study included 55 patients who were treated for mesothelioma between 1997 and 2008.

First, the mesothelioma patients received up to four cycles of chemotherapy (most often a combination of cisplatin and pemetrexed). A few weeks later, patients who were healthy enough had a diagnostic procedure to determine whether they were good candidates for surgery (if the cancer had not spread). A total of 38 patients underwent the entire treatment—induction chemotherapy, then EPP, followed by either external beam radiotherapy (EBRT) or intensity-modulated radiotherapy (IMRT) six to eight weeks later.

Overall, mesothelioma patients who completed chemotherapy, surgery, and radiation survived an average of two years. Patients who received IMRT appear to have a lower risk of cancer recurrence (14.3%) compared with the EBRT group (41.7%). According to the authors, one of the potential advantages of using IMRT is to better target the cancer while sparing nearby organs from radiation exposure.

Based on the results of this study, chemotherapy followed by EPP and radiation seems to be a safe and effective choice for mesothelioma patients. “Our results are definitely good enough for us to continue favoring an induction approach for most of our patients,” Dr. Vallières says.

However, mesothelioma treatments still have a long way to go before they can provide patients with a more favorable outlook. “Personally, I think that we have plateaued, and will maintain the same results until we have better systemic therapy,” according to Dr. Vallières. He says improved chemotherapy or new biologic treatments are needed to improve survival rates.

Source:
Buduhan G, Menon S, Aye R, Louie B, Mehta V, Vallières E. Trimodality therapy for malignant pleural mesothelioma. The Annals of Thoracic Surgery. 2009;88:870-876.

Filed Under: Mesothelioma Treatment Options

Scientists Focus on Compounds that Destroy Mesothelioma Cells

August 7, 2009 By Leave a Comment

Sodium selenite, the most common water-soluble form of selenium, is an antioxidant and redox-modulating compound that can kill mesothelioma cells in cell cultures. Now researchers are discovering why it works. This could potentially lead to new treatments for mesothelioma.

Investigators from the Karolinska Institute in Stockholm, Sweden previously discovered that selenite triggers the death of mesothelioma cells, particularly sarcomatoid cells, which are the least common but deadliest form of this cancer.

In the current study, which was published in the Journal of Experimental & Clinical Cancer Research, the investigators aimed to determine the pathways by which selenite kills mesothelioma cells, and why sarcomatoid cells seem to be most sensitive to selenite treatment. “Developing anticancer drugs is difficult,” explains Gustav Nilsonne, MD, lead study author and researcher in the Department of Laboratory Medicine, Division of Pathology at the Karolinska Institutet. “The key challenge is to find substances that act specifically against cancer cells but not against healthy cells. Selenite appears to have this kind of specificity. We have wanted to understand why the mesothelioma cells respond as they do, and that is why we investigated the cellular signaling mechanisms in response to selenite.”

The design of individual mesothelioma cell types, and the different processes within these cells may help determine how much damage selenite treatment inflicts. To evaluate these pathways, the researchers treated both epithelioid (the most common form of mesothelioma) and sarcomatoid cells with selenite, and then looked at the processes within the cancer cells that caused them to die.

Selenite triggered cell death (apoptosis) in 15% of sarcomatoid cells, compared to just 8% of epithelioid mesothelioma cells. Total cell death after 24 hours of treatment was about 25% in the epithelioid cells and 30% in the sarcomatoid cells. The researchers discovered that the treatment activated different signaling processes in sarcamatoid and epithelioid cells, particularly in Bcl—a family of proteins that either promote or inhibit cell death. Sarcomatoid cells produced excess amounts of a protein in this family called Bax, which promotes cell death. This may be why sarcomatoid cells are more sensitive to the effects of selenite.

Particularly of interest was the discovery that a protein called p53, which is known as the “master regulator” of cell death, built up in the mesothelioma cells after selenite treatment, but the selenite appeared to inactivate this protein so that it had no effect on the cells’ DNA. This finding indicates that selenite treatment must have triggered cancer cell death via other mechanisms besides p53.

“Broadly speaking, our results show that a variety of mechanisms are involved. Selenite does not activate just one single pathway,” Dr. Nilsonne says. “Instead of sounding a distinct note on the cell’s clavier, it triggers several disharmonious chord progressions at the same time, if you will.”

This study provides additional evidence that selenite is a promising new treatment for mesothelioma. However, the use of selenite is still experimental, and further research is needed to confirm its safety and effectiveness. Future studies will also determine whether combining selenite with other cancer drugs might boost its effectiveness on epithelioid mesothelioma cells.
Note: It is important to note that while trace amounts of the element are necessary for cellular function, selenium and selenium salts are toxic in large amounts. If you are interested in using selenium or selenite supplements for any health reason including cancer be sure to consult with your licensed healthcare practitioner.

Source:

Nilsonne G, Olm E, Szulkin A, Mundt F, Stein A, Kocic B, Rundlöf, Fernandes AP, Björnstedt M, Dobra K. Phenotype-dependent apoptosis signaling in mesothelioma cells after selenite exposure. J Exp Clin Cancer Res. 2009;28(1):92.

Filed Under: Mesothelioma Treatment Options

Combination Mesothelioma Therapy Shows Promise

July 8, 2009 By Leave a Comment

The following was taken from http://www.transworldnews.com/NewsStory.aspx?id=99951&cat=10.

The National Institute of Cancerologia in Mexico City, Mexico will shortly be releasing results of a 30-month study to determine the efficacy of a combination drug therapy designed to improve the response and survival rates of pleural mesothelioma patients undergoing chemotherapy.
 
The study, which followed 30 pleural mesothelioma patients from September 2007 to April 2009, was conducted to determine whether a combination of two chemotherapy drugs, liposomal doxorubicin and Cisplatin®, would improve survival rates of these patients.
 
Most single-drug chemotherapy regimes have resulted in response rates of less than 20 percent. Combination therapies, including therapy with non-liposomal doxorubicin and cisplatin, have produced only slight higher response rates of about 25 percent.
 
Researchers hope the liposomal form of doxorubicin will be more readily absorbed by cancer patients, improving survival rates and helping patients remain comfortable longer. Liposomes are “bubble-like” structures composed of the same material as cell membranes, and are often sued to deliver drugs in certain conditions where normal delivery might result in toxic side effects, or where deeper penetration of the affected cells is required.
 
Pleural mesothelioma is the most common form of mesothelioma, affecting the lining of the lungs and developing as a result of asbestos exposure. Pleural mesothelioma develops as the tissue which surrounds the lungs becomes embedded with tiny fibers of inhaled asbestos, and can occur decades after initial exposure. The most prevalent mesothelioma causes include direct or indirect workplace exposures. Currently, there is no cure for mesothelioma, although symptoms can be treated to improve comfort in those affected by the condition.
 
University of Wisconsin Professor Dr. H. Ian Robins, an oncologist who specializes in the treatment of mesothelioma and other cancers, is one of the many US-based physicians who specialize in the study of asbestos-caused cancers. There is no cure for mesothelioma, but many oncologists like Dr. Robins are devoted to the study of this disease and have the hope that a cure is not far off.
Filed Under: Mesothelioma Treatment Options

Llily’s Drug Altima Approved by FDA to Treat Mesothelioma

July 7, 2009 By Leave a Comment

Alimta has been approved for use alone or in combination with other chemotherapies to treat two other advanced forms of lung cancer and mesothelioma, a cancer linked to asbestos exposure.

Because of the lack of research money to find cures and treatments for mesothelioma this approval is very encouraging.

Doctors have been struggling for years to get help for mesothelioma patients. Progress has been made but it has been very slow.
 

Filed Under: Drug Therapy, Mesothelioma Treatment Options

How were workers exposed to asbestos at Chevron:Read here

June 27, 2009 By Leave a Comment

In this deposition we recently took Chevron admits that it did not  stop using asbestos in its Perth Amboy refinery until 1972,  more than 3 decades after learning that asbestos could kill. According to this witness there was more than 12 miles of asbestos on the piping alone in the Perth Amboy. This had the capacity to cause massive exposure to anyone in the area where asbestos was installed or removed. See http://www.mesotheliomalegalblog.com/mesothelioma-litigation/Despite-Knowledge-Chevron-Uses-Asbestos-Causing-Massive-Exposure–1-32495.html

Filed Under: Asbestos Exposure, Asbestos Piping, Asbestos Products, Company Knowledge, Mesothelioma Exposure, Speak Out for Corporate Responsibility

Mesothelioma Treatment Centers by State

May 30, 2009 By Leave a Comment

Treatment Centers for Patients with Mesothelioma

UAB Comprehensive Cancer Center
1824 6th Avenue South
Birmingham, AL
1-(800)-UAB-0933

UAB Comprehensive Cancer Center is one of the nation’s leading cancer research and treatment centers, and is the only National Cancer Institute-designated comprehensive cancer center located in a six-state area that includes Alabama, Mississippi, Louisiana, Arkansas, South Carolina and Georgia. UAB’s cancer services are routinely recognized as being among the nation’s best.

Arizona Cancer Center
1515 North Campbell Ave.
Tucson, AZ 85724-5024
1-(800)-622-COPE

Arizona Cancer Center is one of 40 centers in the nation and the only one headquartered in and serving the entire state of Arizona that has been designated by the National Cancer Institute as a Comprehensive Cancer Center, the NCI’s highest ranking. That designation is reserved for centers focusing on patient care as well as basic and clinical research, prevention, education, outreach and training.

Chao Family Comprehensive Cancer Center
101 The City Drive, Bldg, 23
Route 81
Orange, CA 92868
1-(714)-456-8200

Chao Family Comprehensive Cancer Center is located on the UC Irvine Medical Center campus. The Comprehensive Cancer Center is affiliated with the School of Medicine at the University of California, Irvine. As a university-based facility, the cancer center offers the expertise of a scientific community that is internationally renowned for its work in the prevention, diagnosis and treatment of cancer.

Dr. David Jablons
UCSF Cancer Center
1600 Divisadero Street
San Francisco, CA 94115
1-(415)-885-3882

UCSF Cancer Center‘s long tradition of excellence in cancer research includes, notably, the Nobel Prize-winning work of J. Michael Bishop and Harold Varmus, who discovered cancer-causing oncogenes. Their work opened new doors for exploring genetic mistakes that cause cancer, and formed the basis for some of the most important cancer research happening today.

Dr. Kim Kerstine
City of Hope/Beckman Research Institute
1500 East Duarte Road
Duarte, CA. 91010
1-(800)-826-HOPE

City of Hope/Beckman Research Institute is a national cancer institute (NCI)-designated comprehensive cancer center that offers a full complement of services designed to address all aspects of cancer, from understanding its origins, to developing new therapies and testing them in patient clinical trials, to delivering superior patient care and providing support and education to patients, their families and the public.

Dr. Robert Cameron
UCLA Surgery
10833 Le Conte Ave
Los Angeles, CA. 90095
1-(310)-794-7333

UCLA Surgery’s Thoracic Surgery website provides information on general thoracic surgery, lung diseases, lung cancer, metastatic tumors (sarcomas, colon cancer, etc.), lung volume reduction surgery (emphysema surgery), minimally-invasive and robotic-assisted lung surgery, esophageal diseases, esophageal cancer, acid reflux surgery, achalasia and esophageal motility disorders, hiatal hernia repair, minimally-invasive and robotic-assisted esophageal surgery, pleural diseases, mesothelioma, lung-sparing surgery, biologic therapy, chest wall diseases, sarcomas, pectus Excavatum, pectus Carinatum, chest wall reconstruction, mediastinal diseases, thymoma, neurogenic tumors, minimally-invasive and robotic-assisted surgery, minimally invasive thoracic surgery, robotic-assisted thoracic surgery, surgical adjuvant therapy, immunology, biologic therapy and anti-angiogenic therapy.

Jonsson Comprehensive Cancer Center
8-684 Factor Building
Los Angeles, CA. 90095-1781
1-(310)-825-5268

Jonsson Comprehensive Cancer Center is a renowned cancer research and cancer diagnosis, treatment and prevention center, specializing in mesothelioma. Located at the University of California Los Angeles.

Rebecca and John Moores UCSD Cancer Center
3855 Health Sciences Drive
La Jolla, CA. 92093
1-(858)-822-1222

Rebecca and John Moores UCSD Cancer Center focuses on research, outreach and prevention, and offers clinical trials focusing in on the treatment of mesothelioma. Located in San Diego, California.

USC/Norris Comprehensive Cancer Center
1441 Eastlake Avenue
Los Angeles, CA. 90033
1-(800)-USC-CARE

USC/Norris Comprehensive Cancer Center is a leader in cancer research, with nearly 200 members investigating the complex origins and progression of cancer, developing prevention strategies and searching for cures. USC Norris is part of the Keck School of Medicine and is designated by the National Cancer Institute as one of the nation’s 40 comprehensive cancer centers.

University of Colorado Cancer Center
1665 N. Ursula St.
Aurora, CO. 80045
1-(800)-473-2288

University of Colorado Cancer Center is the Rocky Mountain region’s only National Cancer Institute-designated comprehensive cancer center.Headquartered on the Anschutz Medical Campus, UCCC is a consortium of three state universities and five institutions.

Yale Cancer Center
333 Cedar Street
New Haven, CT. 06520-8028
1-(203)-785-4095

Yale Cancer Center is southern New England’s only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute- and one of only 40 in the nation. The significance of this designation has profound implications for those who choose Yale as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Yale Cancer Center with novel treatment options and expert care.

Dr. Paul Sugarbaker
Washington Cancer Institute
106 Irving Street NW, Suite 3900N
Washington, D.C.20010
1-(202)-877-3908

Washington Cancer Institute at the Washington Cancer Institute at Washington Hospital Center offers advanced services to include specialty treatment programs for gastric cancer, pseudomyxoma peritonei, hepatobiliary (primary and metastatic liver cancer), pancreas cancer, as well as primary peritoneal surface malignancies such as abdominopelvic sarcoma. The center provides services for the following areas: appendix, colorectal with peritoneal carcinomatosis (cancers that spread to the intra-abdominal surfaces), and peritoneal mesothelioma

Lombardi Comprehensive Cancer Center
38 Reservoir Road NW
Washington, D.C.20057
1-(202)-784-4000

Lombardi Comprehensive Cancer Center clinicians are dedicated to providing the best professional care, delivered with compassion, for all patients. Lombardi’s internationally-renowned physicians treat virtually every type of cancer, including breast, lung, colorectal, prostate, head and neck, and cancers of the blood. Along with cutting-edge cancer care, we offer a program of innovative clinical trials and a full range of supportive care services to improve our patients’ health and quality of life, and Lombardi specializes in the care of malignant mesothelioma.

Dr. Larry Robinson
Moffitt Cancer Center Institute
12902 Magnolia Dr
Tampa, FL. 33612
1-(813)-972-8412

Moffitt Cancer Center Institute is an ambitious partnership between patients, doctors and researchers to improve all aspects of cancer prevention and care. Patients participate by donating information and tissue. Researchers use the information to learn about all issues related to cancer and how care can be improved. Clinicians use the information to better educate and care for patients.

Dr. Hedy Lee Kindler
University of Chicago Hospitals
5841 S. Maryland Avenue
Chicago, IL. 60637
1-(773)-702-0360

University of Chicago Hospitals has been a pioneer in the study and treatment of malignant mesothelioma–a rare disease that affects 2,500 to 3,000 people in the United States each year. Their program is comprised of a dedicated team of medical oncologists, surgeons, nurses, pathologists, imaging specialists, and scientists who understand the unique characteristics of this disease. The University of Chicago Hospitals use a team approach with weekly mesothelioma program meetings. Their comprehensive and multidisciplinary focus is a direct reflection of our clinical interest in mesothelioma and their expertise is in developing novel treatment protocols that extend lives.

Robert H. Lurie Cancer Center
Northwestern University
675 N. St. Clair, Galter Pavilion – 21st Floor
Chicago, IL. 60611
1-(312)-908-5250

Robert H. Lurie Cancer Center is committed to being a national leader in the battle to overcome cancer. To this end, Chicago’s Lurie Cancer Center is dedicated to scientific discovery, advancing medical knowledge, providing compassionate, state-of-the-art cancer care, and training the next generation of clinicians and scientists

Dana-Farber Cancer Institute
44 Binney Street
Boston, MA. 02115
1-(800)-320-0022

Dana-Farber Cancer Institute offers care for mesothelioma; malignant patients at Dana-Farber is provided through the Thoracic Cancer Treatment Center. Read about services and clinical research, and see a list of medical staff.

Dr. David J. Sugarbaker
Brigham and Women’s Hospital
75 Francis Street
Boston, MA. 02115
1-(617)-732-6824

Brigham and Women’s Hospital is world-renowned in virtually every area of adult medicine. As a teaching hospital of Harvard Medical School, their leadership in patient quality and safety, development of state-of-the-art treatments and technologies, and robust research programs have improved the health of people around the world. They offer extensive information on the treatment of mesothelioma.

Dr. Mark Krasna
University of Maryland Greenebaum Cancer Center
22 S Greene Street
Baltimore, MD 21201
1-(410)-328-6366

University of Maryland Greenebaum Cancer Center offers modern therapy of mesothelioma, with surgery and chemotherapy as central stage treatment options.. The Cancer Center offers patients hope, with a better understanding of its cellular and molecular pathogenesis novel treatment approach.

Dr. Mark Krasna
Johns Hopkins Oncology Center
401 North Broadway
Baltimore, MD 21231
1-(410)-614-3891

Johns Hopkins Oncology Center is a fully accredited, not-for-profit, regional teaching hospital. Located at 1200 Old York Road (Route 611) in Abington, PA, AMH has been providing comprehensive, high-quality services for people in Montgomery, Bucks and Philadelphia counties for more than 90 years.

Barbara Ann Karmanos Cancer Institute
4100 John R
Detroit, Michigan 48201
1-(800)-KARMANOS

Barbara Ann Karmanos Cancer Institute is a fully accredited, not-for-profit, regional teaching hospital. Located at 1200 Old York Road (Route 611) in Abington, PA, AMH has been providing comprehensive, high-quality services for people in Montgomery, Bucks and Philadelphia counties for more than 90 years.

Dr. Gregory Kalemkerian
University Michigan Cancer Center
1500 E. Medical Center Drive
Ann Arbor, MI. 48109
1-(734)-936-5281

University Michigan Cancer Center is a fully accredited, not-for-profit, regional teaching hospital. Located at 1200 Old York Road (Route 611) in Abington, PA, AMH has been providing comprehensive, high-quality services for people in Montgomery, Bucks and Philadelphia counties for more than 90 years.

Mayo Clinic Cancer Center
200 First Street SW
Rochester, MN. 55905
1-(507)-284-2111

Mayo Clinic Cancer Center is a fully accredited, not-for-profit, regional teaching hospital. Located at 1200 Old York Road (Route 611) in Abington, PA, AMH has been providing comprehensive, high-quality services for people in Montgomery, Bucks and Philadelphia counties for more than 90 years.

University of Minnesota Cancer Center
420 Delaware St. SE
Minneapolis, MN. 55455
1-(612)-624-8484

University of Minnesota Cancer Center is a fully accredited, not-for-profit, regional teaching hospital. Located at 1200 Old York Road (Route 611) in Abington, PA, AMH has been providing comprehensive, high-quality services for people in Montgomery, Bucks and Philadelphia counties for more than 90 years.

Comprehensive Cancer Center
Wake Forest University
Medical Center Boulevard
Winston-Salem, NC. 27157
1-(800)-446-2255

Comprehensive Cancer Center is one of the nation’s oldest NCI-designated cancer centers (1974). CCCWFU recently celebrated its 30th year of delivering quality patient care, providing education and outreach to individuals at risk for developing the disease, and achieving excellence in basic science research.

Dr. David Harpole
Duke University Medical Center
Trent Drive
Durham, NC. 27706
1-(919)-668-8413

Duke University Medical Center is one of only 40 centers in the country designated by the National Cancer Institute (NCI) as a “comprehensive cancer center,” Duke combines cutting-edge research with compassionate care. Their team of nationally recognized physicians and staff treat more than 7,000 new patients per year, giving them the extensive experience that yields better results. The Duke Comprehensive Cancer Center is ranked as one of the top 10 cancer hospitals in the country, according to U.S.News & World Report’s “America’s Best Hospitals” survey.

UNC Lineberger Comprehensive Cancer Center
Manning Drive
Chapel Hill, NC. 27599-7295
1-(919)-966-3036

UNC Lineberger Comprehensive Cancer Center, with support from the state of North Carolina for the construction of the N.C. Cancer Hospital and through the University Cancer Research Fund, treats cancer patients, conducts research into the causes of cancer and searches for new treatments, develops and directs statewide programs in cancer prevention, and trains future physicians, nurses, scientists and public health professionals.

Dr. Brian W. Loggie
Creighton University Medical Center
2500 California Plaza
Omaha, NE 68178
1-(402)-280-4100

Creighton University Medical Center is an academic medical center, teaching tomorrow’s health care professionals while striving for excellence in mesothelioma and cancer diagnosis and treatment. Driven by their passion for patient care, teaching and research, the Creighton University Medical Center provides advanced care for some of the region’s sickest patients, smallest babies and most complex injuries and illnesses. They raise the bar for clinical experience with their expertise in trauma, cardiac care, cancer care, specialized surgery, transfusion-free medicine and high-risk obstetrics.

Norris Cotton Cancer Center
1 Medical Center Drive
Lebanon, NH. 03756
1-(800)-639-6918

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center is one of the nation’s premier facilities for cancer treatment and research. It is one of only 40 National Cancer Institute designated comprehensive cancer centers in the United States, and is rated by US News & World Report as one of the top 50 hospitals for cancer care nationally.
The Cancer Center provides a positive environment for treatment, cure, and recovery for patients with all forms of cancer. Patients receive technologically advanced cancer treatments and access to clinical trials of new treatments. Each patient is seen as an individual, and a specific treatment plan is developed by specialists who work directly with the patient, family, and referring physician. The Cancer Center is also a leader in improving the comfort and quality of life of patients.

Dr. Claire F. Verschraegen
UNM Cancer Treatment Center
900 Camino de Salud NE
Albuquerque, NM. 87131
1-(505)-272-4551

UNM Cancer Treatment Center is the Official Cancer Center of the State of New Mexico, and the only National Cancer Institute-designated cancer center in the state. The UNM Cancer Center offers an unmatched depth and breadth of cancer care in New Mexico.They are home to the state’s largest and most experienced team of cancer specialists, with more than 85 board-certified cancer physicians, representing every area of oncology, and more than 120 cancer researchers. UNM Cancer Treatment Center has been recruited from prestigious institutions from all over the world.

Cancer Research Center
Albert Einstein College of Medicine
1300 Morris Park Avenue
Bronx, NY. 10461
1-(718)-430-2302

Albert Einstein College of Medicine Cancer Research Center was among the first cancer centers on medical school campuses to be funded by the National Cancer Institute in 1972 following passage of the National Cancer Act the previous year. AECC has had continuous center funding by the National Cancer Institute since that time. The goal of AECC is to foster basic, clinical, and translational research that addresses all aspects of the cancer problem. There are programs to cover Epidemiology along with Cancer Control and Prevention. AECC members are involved in cancer-relevant research or collaborative projects with other members whose work has a cancer focus. All AECC members are supported through approved national peer-reviewed funding mechanisms. There are currently over 140 AECC members who represent a broad spectrum of basic and clinical departments.

Dr. Harvey Pass
NYU Comprehensive Cancer Center
530 First Avenue, Suite 9V
New York, NY 10016
1-(212)-263-7417

NYU Comprehensive Cancer Center‘s mission is to discover the origins of human cancer and to use that knowledge to eradicate the personal and societal burden of cancer in our community, the nation and the world. The NYU Cancer Institute takes a multidisciplinary approach to patient care and features a translational research program that brings together laboratory scientists and clinical researchers. The result: the latest advances in cancer care are delivered in a caring and compassionate setting.

Dr. Robert N. Taub, MD
NY Presbyterian Medical Center
161 Fort Washington Avenue
New York, NY 10032
1-(212)-305-4076

NY Presbyterian Medical Centerrecently established a Mesothelioma Center, unique in this area, to provide comprehensive diagnosis and treatment for this uncommon cancer. Mesothelioma originates in the membrane lining the abdominal cavity or the chest cavity, and is often seen in older patients who have been exposed to asbestos. Other causes, such as radiation and certain viruses, have sometimes been implicated. NewYork-Presbyterian Hospital offers patients the latest tools for the assessment of mesothelioma. Under the aegis of the Mesothelioma Center, more than 100 newly diagnosed patients with mesothelioma are cared for and followed each year from all over the country. (The total number of new cases in the U.S. is less than 3,000 per year). Most patients are seen or treated by a surgeon, medical oncologist, and radiotherapist during their course, as well as a highly specialized nursing staff and psychiatry liaison.

Drs. Valerie Rusch and Raja Flores
Memorial Sloan-Kettering
1275 York Avenue
New York, NY 10021
1-(212)-639-2806

Memorial Sloan-Kettering‘s team of mesothelioma experts makes treatment recommendations on an individual basis, taking into account the stage of the cancer, the patient’s general health, and, for patients with pleural mesothelioma, how well the lungs function. Patients who are otherwise in overall good health and who have early-stage mesothelioma may be treated with chemotherapy, followed by surgery and radiation. Patients who cannot tolerate surgery or who have more advanced disease are generally treated with chemotherapy alone. Memorial Sloan-Kettering is researching novel treatments for mesothelioma, and participation in a clinical trial may be offered.

Herbert Irving Comprehensive Cancer Center
622 West 168th Street
New York, NY 10032
1-(212)-305-9327

Herbert Irving Comprehensive Cancer Center of Columbia University is dedicated to the cure of cancer through innovative research, training of researchers and clinicians, and outstanding patient care. The HICCC has been a National Cancer Institute (NCI)-designated cancer center for over 30 years, and is one of only 39 NCI-designated cancer centers in the nation. In partnership with NewYork-Presbyterian Hospital, the cancer center is ranked as one of the top hospitals in the United States. The internationally-recognized researchers and clinicians of the HICCC bring together the best approaches for prevention, diagnosis and treatment of all types of cancer.

Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY. 14263
1-(212)-ROSWELL

Roswell Park Cancer Institute identified cancer research as the core element of its mission. Groundbreaking research by RPCI scientists has led to greater understanding of cancer and to major advances in diagnosis and treatment.

Arthur G. James Cancer Hospital
The Ohio State University Comprehensive Cancer Center

300 W. 10th Avenue
Columbus, OH 43210
1-(800)-293-5066

Arthur G. James Cancer Hospital is one of the nation’s leading comprehensive cancer centers, finding groundbreaking discoveries that are changing the way the world diagnoses, treats and prevents cancer. They are the only freestanding cancer hospital in the Midwest, and their cancer experts offer leading-edge cancer treatments tailored to individual patients because no two cancers, or two patients, are alike.

Case Western Reserve University Hospitals
Wearn 152, 11000 Euclid Avenue
Cleveland, OH. 44106
1-(216)-844-8797

The Case Comprehensive Cancer Center (Case CCC) based at Case Western Reserve University (CWRU) is a partnership organization supporting all cancer related research efforts at CWRU, University Hospitals Case Medical Center, and the Cleveland Clinic. Located in Cleveland, Ohio, the Case CCC serves the cancer research and clinical needs of an urban manufacturing and rural agricultural region containing 3.8 million people in Northern Ohio.

Dr. David P. Mason
Cleveland Clinic Foundation
9500 Euclid Avenue
Cleveland, OH 44195
1-(216)-444-4053

Cleveland Clinic Foundationwas founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey.

Dr. Daniel Sterman
University of Pennsylvania Cancer Center
3400 Spruce Street
Philadelphia, PA. 19104
1-(215)-614-0984

University of Pennsylvania Cancer Centerprovides the full spectrum of treatment of mesothelioma and rare cancers as well as follow-up care. The goal of their cancer treatment center is to eliminate cancer and prevent or reduce the chance of recurrence in the future. They offer various types of cancer therapy, alone or in combinations, depending on the type of cancer as well as other factors, such as stage of tumor, and your medical condition. Your physicians at the University of Pennsylvania will recommend the best combination of treatments for your individual condition and assist in making the choice that’s right for you.

Dr. Joseph S. Friedberg
UPenn at Presybterian
39th and Market Streets
Philadelphia, PA. 19104
1-(215)-662-9195

The Abramson Cancer Center at Penn Presbyterian Medical Center offers patients the latest advances in the prevention, diagnosis and treatment of cancer. Their doctors work closely with other cancer specialists to provide comprehensive, integrated care. Other caregivers who may become involved in your care are doctors and nurses in surgical oncology, radiation oncology, gynecologic oncology, urology, radiology and pathology.

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA. 19111
1-(888)-FOX-CHASE

Fox Chase Cancer Center‘s surgeons, Walter J. Scott, MD, FACS and Abraham “Avi” Lebenthal, MD, offer an individualized tailored surgical approach to the treatment of mesothelioma that integrates the patient functional status and stage. Surgery is often augmented by adjuvant Radiation followed by chemotherapy.

University of Pittsburgh Cancer Institute
5115 Centre Avenue
Pittsburgh, PA 15232
1-(800)-237-4PCI

University of Pittsburgh Cancer Institute is the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in western Pennsylvania. With more than 625 research faculty members specializing in disciplines ranging from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end of life care, UPCI maintains a broad strategic vision and comprehensive approach to understanding and defeating cancer. In 2007, UPCI received nearly $200 million in research grants, and was ranked 11th nationally in funding from the National Cancer Institute.

Dr. David C. Rice
The University of Texas
MD Anderson Cancer Center
1515 Holcombe Blvd
Houston, TX 77030
1-(713)-794-1477

At the University of Texas, the MD Anderson Cancer Center‘s mission is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

Dr. J Michael DiMaio
UT Southwestern Medical Center
5323 Harry Hines Blvd
Dallas, TX. 75390-8879
1-(214)-645-7731

The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center is one of the premier centers in the nation for the study and treatment of cancer. Their commitment to furthering the science of cancer research has enabled the cancer program to achieve dramatic results in UT Southwestern laboratories and health-care facilities.
Established in 1989 through a generous gift from Dallas philanthropist Harold C. Simmons, the Simmons Comprehensive Cancer Center offers a broad-based collection of cancer programs, each providing a wide range of patient-care services. The program receives significant support from the most prestigious cancer research institutions in the nation: the National Cancer Institute, the American Cancer Society, the National Institutes of Health, the Susan G. Komen Foundation, the Lance Armstrong Foundation and the Centers for Disease Control and Prevention.

Dr. Roy Smythe
Scott & White
2401 South 31st Street
Temple, TX 76508
1-(254)-724-2595

Scott & White is committed to patient care, education and research, which has earned their health system a reputation for excellence in cancer, orthopedics and cardiovascular care. Their dedicated physicians have built a nationally-acclaimed health care organization, recognized by organizations including U.S. News & World Report and Newsweek. And for the tenth year, Scott & White Memorial Hospital is listed among the “Top 100 Hospitals” in America for cardiovascular care.

San Antonio Cancer Institute
7703 Floyd Curl Drive
San Antonio, TX. 78229
1-(210)-616-5590

San Antonio Cancer Therapy and Research Center’s total patient care system consists of break-through researchers, state-of-the-art tools and technology and multidisciplinary clinical care, delivered through a team of world-class physicians, laboratory scientists and other medical professionals. The total patient care system allows the center to seamlessly translate the latest research findings more efficiently and directly to patients. They treat the cancer, and care for the patient. Their team of scientists and doctors are committed to conquering cancer one patient at a time.

Vermont Cancer Center
89 Beaumont Avenue
Burlington, VT 05405
1-(802)-656-4414

Vermont Cancer Center is a not-for-profit comprehensive clinical and research cancer center; the only such organization in the state of Vermont. Founded in 1974, the Vermont Cancer Center is located within the University of Vermont (UVM) College of Medicine and enjoys a clinical partnership with Fletcher Allen Health Care, Vermont’s academic medical center with UVM. The Vermont Cancer Center is committed to innovative cancer research, life-saving prevention and treatment programs, public education and scientific collaboration, and serves to influence standards of cancer prevention, screening, diagnosis and care across Vermont and northern New York.

Dr. Eric Vallieres
University of Washington Medical Center
1959 NE Pacific
Seattle, WA 98195
1-(206)-598-4477

University of Washington Medical Center is a fully accredited, not-for-profit, regional teaching hospital. Located at 1200 Old York Road (Route 611) in Abington, PA, AMH has been providing comprehensive, high-quality services for people in Montgomery, Bucks and Philadelphia counties for more than 90 years.

Fred Hutchinson Cancer Research Center
1100 Fairview Avenue N
Seattle, WA 98109
1-(206)-667-5000

The Fred Hutchinson Cancer Research Center, together with its clinical and research partners, the University of Washington, Seattle Children’s and the Seattle Cancer Care Alliance, comprise the Fred Hutchinson/University of Washington Cancer Consortium. The Consortium is among 40 National Cancer Institute-designated comprehensive cancer centers nationwide. Their interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Their researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and the world.

Seattle Cancer Care Alliance
825 Eastlake Avenue E
Seattle, WA 98109
1-(206)-288-1024

Seattle Cancer Care Alliance unites the doctors from Fred Hutchinson Cancer Research Center, UW Medicine, and Seattle Children’s to form a world-class treatment center that provides advanced therapies and clinical studies for cancers and other related diseases.

University of Michigan
Comprehensive Cancer Center
600 Highland Avenue
Madison, WI 53792-6164
1-(800)-622-8922

Comprehensive Cancer Center at the University of Michigan is one of only 40 U.S. centers to earn the National Cancer Institute’s “Comprehensive” designation by meeting strict guidelines for extensive, interactive and innovative clinical and laboratory research; participation in NCI testing of new therapies; significant cancer prevention and control research; provision of patient education, community service and outreach as well as training for health professionals. The Cancer Center is also a founding member of the National Comprehensive Cancer Network, a consortium of 21 premiere cancer centers formed to develop national guidelines to ensure consistent, high-quality and cost-effective cancer care.

Filed Under: Locate a Medical Specialist, Mesothelioma Experts, Mesothelioma Surgery Centers, Mesothelioma Treatment Options

Jobsites in the Northeast Where Asbestos was Used

May 30, 2009 By Leave a Comment

 Until sometime in the mid 1970s the majority of industrial jobsites used asbestos as part of the industrial process. This included construction sites, refineries, powerplants, chemical factories and pharmaceutical companies. For a listing of some of the sites click on the following link.

http://www.mesotheliomalegalblog.com/mesothelioma-litigation/North-East-Asbestos-Job-Sites–1-31368.html

Filed Under: Mesothelioma Exposure, Workplace Exposure: Mesothelioma and Asbestos
« Older Posts
Newer Posts »